Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07321652
Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Phase 3 · United States · 261 sites
Registry update: 3 Nov 2026
NCT07387263
Recruiting
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
Not applicable · Canada · 2 sites
Registry update: 30 Oct 2026
NCT07495020
Recruiting
The Transit Bipartition With the Use of a Metallic Anastomosis Clip and Circular Fundocorporeal Gastroplication
Not applicable · Kazakhstan · 1 site
Registry update: 7 May 2026
NCT07557953
Recruiting
A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
Phase 1 · Germany · 1 site
Registry update: 15 May 2026
Conflicting statuses (not updated in the registry for 5 months)
NCT07446322
Recruiting
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Phase 2 · United States · 20 sites
Registry update: 5 Nov 2026
NCT07593027
Recruiting
A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.
Phase 1/2 · China · 26 sites
Registry update: 22 Jul 2026
NCT07381634
Recruiting
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
Phase 2 · China · 1 site
Registry update: 4 Aug 2026
NCT07571161
Recruiting
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
Phase 3 · China · 30 sites
Registry update: 24 Aug 2026
NCT07579936
Recruiting
A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens
Phase 2 · China · 1 site
Registry update: 12 May 2026
NCT07447648
Recruiting
Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
Not applicable · France, Italy, Netherlands · 13 sites
Registry update: 21 Aug 2026
NCT07362186
Recruiting
LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
Phase 3 · China · 1 site
Registry update: 11 May 2026
NCT07532538
Recruiting
A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
Not applicable · China · 1 site
Registry update: 2 Sept 2026
NCT07768579
Recruiting
The Effect of Sequential Therapy on Alzheimer's Disease
Not applicable · China · 1 site
Registry update: 19 Aug 2026
NCT07496372
Recruiting
A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced Heart Failure(NYHA III-IV)
Phase 3 · China · 1 site
Registry update: 12 May 2026
NCT07554521
Recruiting
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
Phase 2 · United States · 9 sites
Registry update: 16 Oct 2026
NCT07561723
Recruiting
IMP3-saRNA Vaccine in Advanced NSCLC
Phase 1 · China · 1 site
Registry update: 12 May 2026
NCT07493148
Recruiting
Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL
Phase 2 · China · 1 site
Registry update: 25 Mar 2026
NCT07513181
Recruiting
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Phase 2 · Poland, United States · 16 sites
Registry update: 21 Sept 2026
NCT07502508
Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Phase 2 · United States · 20 sites
Registry update: 20 Oct 2026
NCT07286149
Recruiting
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Phase 1/2 · Brazil, Chile, China, Germany, Spain, Greece, Hong Kong, Hungary, Israel, Italy, South Korea, Poland, United States · 39 sites
Registry update: 1 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.